April 09, 2019

Generium Launches First Biosimilar of Eculizumab; Becomes Fifth Marketed Product Using Selexis SUREtechnology Platform

Read More
April 08, 2019

Selexis Earns Spot Among the “Best Workplaces in Switzerland” for Second Consecutive Year

Read More
March 28, 2019

Selexis Bolsters Business Development Team to Support Expanding Base of Partners Relying on Its SUREtechnology to Advance Complex Biologics and Vaccines

Read More
February 26, 2019

Selexis SA and Turgut Pharmaceuticals Expand Biosimilar Development Relationship by Signing Two Commercial License Agreements

Read More
January 09, 2019

Selexis Expands Strategic Immuno-Oncology Alliance with Agenus

Read More